The US pharmaceutical company Johnson & Johnson (J&J) obtained a net profit of 210 million dollars (188 million euros) in the third quarter of 2026, which represents a 96% decrease from the result recorded in the same period of the previous year. In this sense, the multinational led by the Spanish Joaquín Duato [...] La entrada Johnson & Johnson wins a 96% decrease in the third trimester by atypicals aparece primero en Forbes España.